文献速递慢性肾脏病

慢性肾脏病患者对流感疫苗和COVID-19疫苗的认知:来自慢性肾功能不全队列(CRIC)研究的发现

Perceptions About Influenza and COVID-19 Vaccines Among People With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
PubMed 文献 · Am J Kidney Dis · 2025-09-17

该横断面调查纳入278名CRIC研究参与者,于2022年7月至2023年6月完成问卷,评估流感与COVID-19疫苗犹豫情况。结果显示流感疫苗犹豫47人(16.9%)、COVID-19疫苗犹豫46人(16.8%),感知疫苗危害和疫苗怀疑论与疫苗犹豫正相关,感知疫苗益处与之负相关。

要点

  • 流感疫苗犹豫47/278(16.9%),COVID-19疫苗犹豫46/278(16.8%)。
  • 感知疫苗危害(如疫苗导致流感)与疫苗犹豫正相关,Δ均值1.25(95%CI 0.96-1.55)。
  • 感知疫苗益处(如流感疫苗预防重病)与疫苗犹豫负相关,-0.93(95%CI -1.23至-0.62)。

核心结论

  • 在慢性肾脏病患者中,感知疫苗危害和疫苗怀疑论是疫苗犹豫的重要因素。
  • 通过量身定制的患者教育举措改进准确疫苗信息的传播,可能提高该人群的疫苗接种率。

研究设计与样本

  • 横断面调查,纳入来自慢性肾功能不全队列(CRIC)研究3个研究中心的参与者子集。
  • 共278名CRIC参与者在2022年7月至2023年6月期间完成调查。

主要发现

  • 流感疫苗犹豫47人(16.9%),COVID-19疫苗犹豫46人(16.8%)。
  • 感知疫苗危害(如疫苗导致流感)与疫苗犹豫正相关,Δ均值1.25(95%CI 0.96-1.55)。
  • 疫苗怀疑论(如流感疫苗益处被夸大)与疫苗犹豫正相关,Δ均值0.96(95%CI 0.65-1.26)。
  • 感知疫苗益处(如流感疫苗预防重病)与疫苗犹豫负相关,Δ均值-0.93(95%CI -1.23至-0.62)。
  • 超过40%认为自身无流感风险,但该感知与疫苗犹豫无关(Δ均值0.02,95%CI -0.35至0.40);COVID-19结果总体一致,但疫苗怀疑论更普遍且与疫苗犹豫关联更强。

临床怎么用

  • 作者认为,通过量身定制的患者教育举措改进准确疫苗信息的传播,可能提高该人群的疫苗接种率。

局限性

  • 研究人群为参加队列研究并自愿回答调查的慢性肾脏病患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Vaccine uptake among individuals with chronic kidney disease (CKD) is suboptimal. Understanding the perceptions associated with vaccine hesitancy can help inform programs aimed at addressing these concerns. STUDY DESIGN: Cross-sectional survey. SETTING & PARTICIPANTS: A subset of participants from the Chronic Renal Insufficiency Cohort (CRIC) Study, recruited from 3 study sites. EXPOSURE: Participants' perceptions about influenza and COVID-19 infection risks, benefits and harms of vaccines, vaccine skepticism, access barriers, and cues to action, according to the Health Belief Model. OUTCOME: Influenza and COVID-19 vaccine hesitancy, defined as being uncertain about or not planning to receive a future dose of these vaccines. ANALYTICAL APPROACH: Responses were measured on a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree). Linear regression models were used to analyze differences in mean Likert scale scores between participants with and without vaccine hesitancy. RESULTS: Between July 2022 and June 2023, 278 CRIC participants completed the survey, of whom 47 (16.9%) and 46 (16.8%) had influenza and COVID-19 vaccine hesitancy, respectively. Linear regression models identified key perceptions associated with vaccine hesitancy, including perceived harms of the vaccines (eg, the vaccine causes influenza; ΔMean Likert scale, 1.25 [95% CI, 0.96-1.55]) and vaccine skepticism (eg, benefits of the influenza vaccine are exaggerated, 0.96 [95% CI, 0.65-1.26]). Perceived benefits were negatively associated with vaccine hesitancy (eg, influenza vaccines prevent serious illness, -0.93 [-1.23 to -0.62]). More than 40% perceived that they were not at risk of influenza, but this perception was not associated with vaccine hesitancy (0.02 [-0.35 to 0.40]). These findings were overall consistent for COVID-19, although vaccine skepticism was more prevalent and more strongly associated with vaccine hesitancy. LIMITATIONS: The study population consisted of individuals with CKD who were enrolled in a cohort study and voluntarily responded to the survey. CONCLUSIONS: Among individuals with CKD, perceptions of vaccine harms and vaccine skepticism were significant factors contributing to vaccine hesitancy. Improved dissemination of accurate vaccine information through tailored patient education initiatives may enhance vaccination uptake in this population. PLAIN-LANGUAGE SUMMARY: People with chronic kidney disease (CKD) are at higher risk for infections, but some are hesitant to get vaccines. This study surveyed 278 CKD patients to understand why some avoid flu and COVID-19 vaccines. The study found about 17% were hesitant about each vaccine. People who were hesitant often believed the vaccines could be harmful or doubted their benefits. For example, some thought the flu vaccine could cause the flu or that vaccine benefits were exaggerated. By contrast, those who believed vaccines prevent serious illness were less hesitant. These findings suggest that clear, trustworthy information about vaccine safety and effectiveness-shared in ways that address patient concerns-could help increase vaccination rates in people with CKD.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Zou G, Jaar BG, Lash JP, et al. Perceptions About Influenza and COVID-19 Vaccines Among People With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2025. PMID: 40972704. doi:10.1053/j.ajkd.2025.07.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。